KSHV continually evades the innate immune response using several approaches, like suppressing TGF-β signaling [45], activation of NF-κB response genes [65] and encoding trace amounts of v-IL6, a truncated version of human IL-6, during latent infection [66]. Here, TGFB1 is linked to disease arising from reactivation of latent virus.